Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Researchers investigate hidden risks of routine eye drops in hospital patients

NCT ID NCT07178600

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 33 times

Summary

This study aims to find out which hospitalized patients are more likely to experience side effects from a specific eye drop combination (tropicamide/phenylephrine) used to dilate the pupil before eye surgery. Researchers will monitor 1,000 patients before and after receiving the drops, checking vital signs and asking about any reactions. The goal is to better understand what factors increase the risk of side effects, such as high blood pressure or eye discomfort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Instituto de Oftalmología FAP Conde de Valenciana, IAP Sede Centro

    RECRUITING

    Mexico City, Mexico Ciy, 06800, Mexico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.